Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury

精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用

基本信息

  • 批准号:
    10470346
  • 负责人:
  • 金额:
    $ 9.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-15 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Heart disease is the leading cause of death in the United States and together with cerebrovascular diseases account for over 28% of total deaths in the United States. Acute cardiac events (e.g., myocardial infarction, stress cardiomyopathy, and sudden cardiac death) are concerning because of their unpredictability and the lack of knowledge regarding causative mechanisms. Psychosocial stressors (e.g., anxiety, personality traits, social isolation) overburden the cardiovascular system and are risk factors for cardiovascular events and stroke. Characterization of heart-brain interactions in the context of psychosocial stress is an important first step in identifying gene-environment interactions that are associated with increased disease risk. Researchers have proposed that emotional and psychosocial stress may lead to a sympathetic-catecholaminergic surge that decreases myocyte viability and/or cardiac function. Hypothalamic arginine-vasopressin (AVP) and the V1A receptor (V1AR) have great therapeutic potential for psychosocial stress-associated heart disease, as AVP and its receptors promote health and survival by regulating neuroendocrine stress responses. The main thesis of this proposal is that AVP, acting via the V1AR, promotes health and wellbeing by dynamically modulating neural responses in the ventral tegmental area (VTA) to stressors. AVP is linked to stress-related disorders in humans and altered emotional reactivity in animals, that can be modulated by antipsychotic treatment, suggesting an AVP-VTA interaction in stress-associated responses. However, the neural mechanisms that underlie the relationships among AVP, Avpr1a gene expression, VTA-dependent stress responses, and cardiovascular function have not been fully characterized. To address this gap in knowledge, the major goals of this proposal are to investigate the cardioprotective properties of the neuropeptide AVP and determine whether there is an association between the Avpr1a gene expression, catecholamine release, and heart disease outcomes in a psychosocial stress-induced myocardial injury animal model. Many susceptible individuals are exposed to multiple risk factors that often interact with each other, magnifying cardiovascular disease risk. Using the Syrian hamster, I plan to investigate the interaction between two psychosocial risk factors, social isolation and aggression. Aim 1 will test the hypothesis that AVP in the VTA blocks stress-induced catecholamine release and exacerbation of myocardial ischemia-reperfusion injury, and aim 2 will test the hypothesis that V1AR gene expression patterns will predict response to stress and AVP- treatment on heart injury and catecholamines. The trainee will also participate in career development activities: learn how to perform myocardial ischemia-reperfusion injury surgeries and conduct gene expression studies; participate in a formal career development program; participate in a special program in cardiovascular genetics and epidemiology; complete scientific courses to gain new knowledge; improve grant writing skills by receiving mentorship from experienced investigators; and establish a successful independent research program.
项目摘要/摘要 心脏病是美国的主要死亡原因,并与脑血管一起 疾病占美国总死亡人数的28%以上。急性心脏事件(例如,心肌 梗塞,压力心肌病和心脏突然死亡)是因为它们的不可预测性 以及缺乏有关因果机制的知识。社会心理压力源(例如,焦虑,个性 特征,社会隔离)心血管系统负担过重,是心血管事件的风险因素和 中风。在社会心理压力的背景下,心灵互动的表征是重要的第一 识别与疾病风险增加有关的基因环境相互作用。研究人员 已经提出,情绪和社会心理压力可能会导致交感神经激素能激增, 降低心肌活性和/或心脏功能。下丘脑精氨酸 - 维息蛋白(AVP)和V1A 受体(V1AR)具有与AVP相关心脏病相关心脏病的巨大治疗潜力 及其受体通过调节神经内分泌压力反应来促进健康和生存。主要论文 该建议的是,通过V1AR行动,AVP通过动态调节来促进健康和福祉 腹侧对盖区域(VTA)对压力源的神经反应。 AVP与压力相关的疾病有关 人类和动物的情绪反应改变,可以通过抗精神病药物来调节 在应力相关反应中提出AVP-VTA相互作用。但是,神经机制 是AVP,AVPR1A基因表达,VTA依赖性压力反应和 心血管功能尚未完全表征。为了解决这一知识的差距,主要目标 该建议的是研究神经肽AVP的心脏保护特性和 确定AVPR1A基因表达,儿茶酚胺之间是否存在关联 释放和心脏病结局在心理压力引起的心肌损伤动物模型中。 许多易感人群暴露于经常相互作用的多种风险因素,放大 心血管疾病风险。使用叙利亚仓鼠,我计划研究两个 社会心理风险因素,社会隔离和侵略。 AIM 1将检验VTA中AVP的假设 阻止压力引起的儿茶酚胺释放和加剧心肌缺血 - 再灌注损伤,并 AIM 2将检验以下假设:V1AR基因表达模式将预测应力和AVP的反应 对心脏损伤和儿茶酚胺的治疗。学员还将参加职业发展活动: 了解如何进行心肌缺血 - 再灌注损伤手术并进行基因表达研究; 参加正式的职业发展计划;参加心血管遗传学的特殊计划 和流行病学;完整的科学课程以获得新知识;通过接受提高赠款写作技巧 经验丰富的研究人员的指导;并建立成功的独立研究计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mario Gil其他文献

Mario Gil的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mario Gil', 18)}}的其他基金

Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
  • 批准号:
    10671052
  • 财政年份:
    2021
  • 资助金额:
    $ 9.91万
  • 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
  • 批准号:
    10283131
  • 财政年份:
    2021
  • 资助金额:
    $ 9.91万
  • 项目类别:

相似国自然基金

基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
长链非编码RNA MIPRL在急性心肌梗塞中的作用及分子机制
  • 批准号:
    81870275
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
Cdx2+胎盘干细胞移植治疗急性心肌梗塞的实验研究
  • 批准号:
    81270281
  • 批准年份:
    2012
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目
LPA在急性心梗诱发心律失常中的作用及其电生理机制
  • 批准号:
    81170163
  • 批准年份:
    2011
  • 资助金额:
    14.0 万元
  • 项目类别:
    面上项目
心肌缺氧/再灌注与细胞移植多功能集成微流控芯片模型构建及应用
  • 批准号:
    21175107
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Long-term exposure to arsenic, and the co-occurrence of uranium, in public and private drinking water: associations with cardiovascular and chronic kidney diseases in the California Teachers Study
公共和私人饮用水中长期接触砷以及同时存在铀:加州教师研究中与心血管和慢性肾脏疾病的关联
  • 批准号:
    10677410
  • 财政年份:
    2023
  • 资助金额:
    $ 9.91万
  • 项目类别:
3D Bioprinting of a Bioelectric Cell Bridge for Re-engineering Cardiac Conduction
用于重新设计心脏传导的生物电细胞桥的 3D 生物打印
  • 批准号:
    10753836
  • 财政年份:
    2023
  • 资助金额:
    $ 9.91万
  • 项目类别:
Mindfulness and Behavior Change to Reduce Cardiovascular Disease Risk in Older People with HIV
正念和行为改变可降低老年艾滋病毒感染者的心血管疾病风险
  • 批准号:
    10762220
  • 财政年份:
    2023
  • 资助金额:
    $ 9.91万
  • 项目类别:
Neural Inflammation and Exercise Pressor Reflex in Heart Failure
心力衰竭中的神经炎症和运动升压反射
  • 批准号:
    10712202
  • 财政年份:
    2023
  • 资助金额:
    $ 9.91万
  • 项目类别:
Mechanisms of Cardiac Injury Resolution by CX3CR1+ Macrophages
CX3CR1巨噬细胞解决心脏损伤的机制
  • 批准号:
    10719459
  • 财政年份:
    2023
  • 资助金额:
    $ 9.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了